A functional polymorphism in the Eta-1 promoter is associated with allele specific binding to the transcription factor Sp1 and elevated gene expression

Molecular Immunology

Volumn 43, Issue 7, 2006, Pages 980-986

  Hummelshoj, Tina ^a   Ryder, Lars P ^a   Madsen, Hans O ^a   Odum, Niels ^b   Svejgaard, Arne ^a  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cytokines; Eta 1; Gene regulation; Human; Osteopontin

Indexed keywords

CYTOKINE; EARLY T LYMPHOCYTE ACTIVATOR 1; LUCIFERASE; OSTEOPONTIN; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CELL LINE; CONTROLLED STUDY; DNA POLYMORPHISM; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HAPLOTYPE; HUMAN; HUMAN CELL; MONOCYTE; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; REPORTER GENE; TH1 CELL; TH2 CELL;

ALLELES; BASE SEQUENCE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; LUCIFERASES; MOLECULAR SEQUENCE DATA; OSTEOPONTIN; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); SIALOGLYCOPROTEINS; SP1 TRANSCRIPTION FACTOR; UP-REGULATION;

EID: 29144486802     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2005.05.012     Document Type: Article

References (22)

1. S. Ashkar, G.F. Weber, V. Panoutsakopoulou, M.E. Sanchirico, M. Jansson, S. Zawaideh, S.R. Rittling, D.T. Denhardt, M.J. Glimcher, and H. Cantor Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity Science 287 2000 860 864
2. M.R. Briggs, J.T. Kadonaga, S.P. Bell, and R. Tjian Purification and biochemical characterization of the promoter-specific transcription factor, Sp1 Science 234 1986 47 52
3. D. Chabas, S.E. Baranzini, D. Mitchell, C.C. Bernard, S.R. Rittling, D.T. Denhardt, R.A. Sobel, C. Lock, M. Karpuj, R. Pedotti, R. Heller, J.R. Oksenberg, and L. Steinman The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease Science 294 2001 1731 1735
4. A. Chiocchetti, M. Indelicato, T. Bensi, R. Mesturini, M. Giordano, S. Sametti, L. Castelli, F. Bottarel, M.C. Mazzarino, L. Garbarini, F. Giacopelli, G. Valesini, C. Santoro, I. Dianzani, U. Ramenghi, and U. Dianzani High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity/lymphoproliferation Blood 103 2004 1376 1382
5. S. D'Alfonso, N. Barizzone, M. Giordano, A. Chiocchetti, C. Magnani, L. Castelli, M. Indelicato, F. Giacopelli, M. Marchini, R. Scorza, M.G. Danieli, M. Cappelli, S. Migliaresi, B. Bigliardo, M.G. Sabbadini, E. Baldissera, M. Galeazzi, G.D. Sebastiani, G. Minisola, R. Ravazzolo, U. Dianzani, and P. Momigliano-Richiardi Two single-nucleotide polymorphisms in the 5′ and 3′ ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus Arthritis Rheum. 52 2005 539 547
6. A.C. Forton, M.A. Petri, D. Goldman, and K.E. Sullivan An osteopontin (SPP1) polymorphism is associated with systemic lupus erythematosus Hum. Mutat. 19 2002 459
7. F. Giacopelli, R. Marciano, A. Pistorio, P. Catarsi, S. Canini, G. Karsenty, and R. Ravazzolo Polymorphisms in the osteopontin promoter affect its transcriptional activity Physiol. Genomics 20 2004 87 96
8. D.D. Hu, E.C. Lin, N.L. Kovach, J.R. Hoyer, and J.W. Smith A biochemical characterization of the binding of osteopontin to integrins alpha v beta 1 and alpha v beta 5 J. Biol. Chem. 270 1995 26232 26238
9. J.T. Kadonaga, K.R. Carner, F.R. Masiarz, and R. Tjian Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain Cell 51 1987 1079 1090
10. K. Kikuchi, A. Tanaka, H. Miyakawa, Y. Kawashima, N. Kawaguchi, M. Matsushita, and M.E. Gershwin Eta-1/osteopontin genetic polymorphism and primary biliary cirrhosis Hepatol. Res. 26 2003 87 90
11. S. Mochida, M. Hashimoto, A. Matsui, M. Naito, M. Inao, S. Nagoshi, M. Nagano, T. Egashira, S. Mishiro, and K. Fujiwara Genetic polymorphims in promoter region of osteopontin gene may be a marker reflecting hepatitis activity in chronic hepatitis C patients Biochem. Biophys. Res. Commun. 313 2004 1079 1085
12. S. Nagai, S. Hashimoto, T. Yamashita, N. Toyoda, T. Satoh, T. Suzuki, and K. Matsushima Comprehensive gene expression profile of human activated T(h)1- and T(h)2-polarized cells Int. Immunol. 13 2001 367 376
13. M. Niino, S. Kikuchi, T. Fukazawa, I. Yabe, and K. Tashiro Genetic polymorphisms of osteopontin in association with multiple sclerosis in Japanese patients J. Neuroimmunol. 136 2003 125 129
14. M. Ono, T. Yamamoto, and M. Nose Allelic difference in the nucleotide sequence of the Eta-1/Op gene transcript Mol. Immunol. 32 1995 447 448
15. V. Ophascharoensuk, C.M. Giachelli, K. Gordon, J. Hughes, R. Pichler, P. Brown, L. Liaw, R. Schmidt, S.J. Shankland, C.E. Alpers, W.G. Couser, and R.J. Johnson Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis Kidney Int. 56 1999 571 580
16. A.W. O'Regan, J.M. Hayden, and J.S. Berman Osteopontin augments CD3-mediated interferon-gamma and CD40 ligand expression by T cells, which results in IL-12 production from peripheral blood mononuclear cells J. Leukoc. Biol. 68 2000 495 502
17. R. Patarca, G.J. Freeman, R.P. Singh, F.Y. Wei, T. Durfee, F. Blattner, D.C. Regnier, C.A. Kozak, B.A. Mock, and H.C. Morse III Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene. Definition of a novel T cell-dependent response associated with genetic resistance to bacterial infection J. Exp. Med. 170 1989 145 161
18. R. Patarca, R.A. Saavedra, and H. Cantor Molecular and cellular basis of genetic resistance to bacterial infection: the role of the early T-lymphocyte activation-1/osteopontin gene Crit. Rev. Immunol. 13 1993 225 246
19. D. Wang, S. Yamamoto, N. Hijiya, E.N. Benveniste, and C.L. Gladson Transcriptional regulation of the human osteopontin promoter: functional analysis and DNA-protein interactions Oncogene 19 2000 5801 5809
20. G.F. Weber, S. Ashkar, and H. Cantor Interaction between CD44 and osteopontin as a potential basis for metastasis formation Proc. Assoc. Am. Phys. 109 1997 1 9
21. T. Yamate, H. Tsuji, N. Amasaki, M. Iguchi, T. Kurita, and K. Kohri Analysis of osteopontin DNA in patients with urolithiasis Urol. Res. 28 2000 159 166
22. M.F. Young, J.M. Kerr, J.D. Termine, U.M. Wewer, M.G. Wang, O.W. McBride, and L.W. Fisher cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin (OPN) Genomics 7 1990 491 502